Dr Pouya Faridi is the head of the Translational Antigen Discovery Laboratory at the School of Clinical Sciences at Monash Health, Monash University. Following completion of his pharmacy doctorate and PhD at the Shiraz University of Medical Sciences, Iran, he joined Prof Ruedi Aebersold’s laboratory at Institute for Molecular Systems Biology at the ETH Zurich, Switzerland. In 2016, he moved to Australia and joined Prof Tony Purcell’s lab at Biomedicine Discovery Institute, Monash University. In 2021, he established his own laboratory at the Department of Medicine, Monash University.
Dr Faridi has developed mass spectrometry and proteomics technologies for the identification and quantification of peptides, proteins and metabolites. He has applied these technologies for the identification and validation of actionable targets for cancer immunotherapy. Some of the peptides that he identified are currently in use for cancer vaccination clinical studies. In addition to his research lab, Dr Faridi is the co-director of the Monash Clinical Proteomics Facility.
Dr Faridi’s research excellence is shown by the mid-career fellowship from the Victorian Cancer Agency for the development of precision vaccines for devastating paediatric brain tumours. He has several patents in the antigen discovery field and his research has been published in prestigious journals including Cell, Science Immunology, Nature Communications and Cancer Immunology Research. Faridi lab is supported by NHMRC, Cancer Australia, Australian Melanoma Research Foundation and Isabella & Marcus Foundation.
Find out more about Dr Pouya Faridi.